Cholinergic Composition for Autonomic Dysfunction Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for autonomic dysfunction and its associated conditions, such as dysautonomia and multiple organ dysfunction, often focus on symptom management rather than addressing the underlying causes, leading to inadequate relief and adverse side effects.

Innovation Solution

A composition comprising a choline compound, a cholinesterase inhibitor, and Acetyl-L-Carnitine is used to treat autonomic dysfunctions and vascular diseases, targeting the root causes of symptoms like constipation, gastroparesis, and low growth hormone production, while also preventing autoimmune disorders and vascular disorders.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current treatments for autonomic dysfunction focus on symptom management, then symptom relief is provided, but underlying causes are not addressed leading to inadequate relief and adverse side effects

Engineering Contradiction:
Improveeffectiveness of treatmentVSAvoidadverse side effects
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent combines multiple cholinergic agents (choline compound, cholinesterase inhibitor, and Acetyl-L-Carnitine) into a single composition that works synergistically to address both symptoms and underlying causes of autonomic dysfunction, thereby improving treatment effectiveness while avoiding the adverse side effects associated with monotherapies

Inventive Principle:
Principle #5Merging (Combining)

2Loss of time

If symptom management approaches are used, then immediate relief may be achieved, but the root causes of conditions like constipation, gastroparesis, and low growth hormone production remain unaddressed

Engineering Contradiction:
Improvetime to symptomatic reliefVSAvoidcorrection of underlying causes
Core Design Contradiction:
Loss of timeVSReliability

Solution Approach 1:

The patent employs a composition that preliminarily restores cholinergic neurotransmission function before addressing specific symptoms, thereby providing both immediate symptomatic relief and long-term correction of underlying causes through the combined action of choline compound, cholinesterase inhibitor, and Acetyl-L-Carnitine

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS9271953B2Methods for correction of organ dysfunction
Publication Date: 2016.03.01 GENETIC DISEASE INVESTIGATORS
  • US9271953B2 patent drawing
  • US9271953B2 patent drawing
  • US9271953B2 patent drawing

AI summary

The present invention includes compositions and methods for treating certain conditions, the composition comprising a choline compound; a cholinesterase inhibitor; and Acetyl-L-Carnitine, wherein the composition is used to treat at least one of autonomic dysfunctions or vascular diseases.